Advertisement

Ads Placeholder
Loading...

Bio-Rad Laboratories, Inc.

BIO-B•NYSE
Healthcare
Medical - Devices
$280.30
$2.05(0.74%)
U.S. Market opens in 20h 0m

Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.6B
P/E Ratio9.94
EPS (TTM)$27.85
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$266.26
3 Months$209.72
1 Year Target$88.35

BIO-B Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO-B) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $88.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.94 and a market capitalization of 7.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.74%
5-Day Change
4.38%
1-Month Change
4.24%
3-Month Change
-9.78%
6-Month Change
-1.61%
Year-to-Date (YTD) Change
-9.78%
1-Year Change
15.83%
3-Year Change
-39.60%
5-Year Change
-51.62%
All-Time (Max) Change
2035.62%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

77,000 Employees
IPO DateSep 21, 1999
CountryUS
Actively Trading

Frequently Asked Questions